GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CurveBeam AI Ltd (ASX:CVB) » Definitions » Total Receivables

CurveBeam AI (ASX:CVB) Total Receivables : A$3.47 Mil (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is CurveBeam AI Total Receivables?

CurveBeam AI's Total Receivables for the quarter that ended in Dec. 2023 was A$3.47 Mil.


CurveBeam AI Total Receivables Historical Data

The historical data trend for CurveBeam AI's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CurveBeam AI Total Receivables Chart

CurveBeam AI Annual Data
Trend Jun21 Jun22 Jun23
Total Receivables
- - 4.18

CurveBeam AI Semi-Annual Data
Jun21 Dec21 Jun22 Jun23 Dec23
Total Receivables - - - 4.18 3.47

CurveBeam AI Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables


CurveBeam AI Total Receivables Related Terms

Thank you for viewing the detailed overview of CurveBeam AI's Total Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


CurveBeam AI (ASX:CVB) Business Description

Traded in Other Exchanges
N/A
Address
10?16 Queen Street, Level 10, Melbourne, VIC, AUS, 3000
CurveBeam AI Ltd is a manufacturer of specialized imaging equipment that has developed software that, through the use of artificial intelligence (AI), and deep learning AI (DLAI), automates the scan processing and analysis of the high-quality images produced from the Company's CT devices to assist in the clinical assessment and management of musculoskeletal health conditions, with a focus on orthopedic and bone health issues. The Company is the first to market with natural bilateral weight-bearing and non-weight-bearing CT, point-of-care imaging equipment with targeted proprietary AI solutions.

CurveBeam AI (ASX:CVB) Headlines

No Headlines